Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Atreca Inc BCEL

Alternate Symbol(s):  COLUF

Atreca, Inc. is a clinical-stage biopharmaceutical company. The Company is discovering and developing antibody-based therapeutics to treat a range of solid tumor types. Its most advanced product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal and breast cancer samples from multiple patients. It commenced clinical development of ATRC-101 with a Phase Ib clinical trial evaluating ATRC-101 as a monotherapy in patients with select solid tumors and opens a new cohort to evaluate ATRC-101 in combination with pembrolizumab, a PD-1 checkpoint inhibitor. It is also advancing additional product candidates using its discovery platform. Its oncology programs include APN-497444, an ADC against a tumor glycan target, and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target.


PINL:BCEL - Post by User

Bullboard Posts
Comment by TheHoboon Dec 29, 2010 11:11am
342 Views
Post# 17901569

RE: RE: remember

RE: RE: rememberRuby, you throw around useless numbers of "See you at 7 bucks" yet you have zero information to back that up; I'd really like to hear your take on what is going to drag down a stock that's sitting on this kind of deposit.

I'd also like you to explain the direct upward momentum of the stock (Today for example, even in light trading it continues an upward climb).  So put the rhetoric aside, have a nice scotch to clear the headache from your massive losses shorting the stock and try to speak intelligently -- if that's possible. 

I'd like to see you also explain away the 1 year return of 55 percent.. Can you do that? Or are you just going to blow more smoke from your (loose) ass?

Or maybe try and respond to these questions (Close your mouth for a second, and breathe through your nose, formulate a complete sentence, and then resume mouth breathing and typing):

- The 20 day moving average is above the 50 day; this indicates a bullish trend.  How does that indicate a $7 SP monkeypants?

- The stochastic oscillator is above 20 and well below 80; do you know what that means my mouth breathing friend? Can you explain that away at all? I didn't think so.

I don't honestly expect you to respond in any intelligent manner.. I'm sure there will be more blustering, empty threats and pathetic rhetoric.


Bullboard Posts